TRAIL/Apo2L Ligand Selectively Induces Apoptosis and Overcomes Drug Resistance in Multiple Myeloma: Therapeutic Applications

Blood - United States
doi 10.1182/blood.v98.3.795
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Gambogic Acid Inhibits Growth, Induces Apoptosis, and Overcomes Drug Resistance in Human Colorectal Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2015English

Targeting CD47/TNFAIP8 by miR-155 Overcomes Drug Resistance and Inhibits Tumor Growth Through Induction of Phagocytosis and Apoptosis in Multiple Myeloma

Haematologica
Hematology
2019English

Resistance of Prostate Cancer Cells to Soluble TNF-related Apoptosis-Inducing Ligand (TRAIL/Apo2L) Can Be Overcome by Doxorubicin or Adenoviral Delivery of Full-Length TRAIL

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2002English

Myxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma Cells

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2016English

Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

The Novel Immunotoxin HM1.24-ETA′ Induces Apoptosis in Multiple Myeloma Cells

Blood Cancer Journal
OncologyHematology
2014English

Enhanced Tumor Killing by Apo2L/Trail and CPT-11 Co-Treatment Is Associated With P21 Cleavage and Differential Regulation of Apo2L/Trail Ligand and Its Receptors

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

Cyclic AMP Induces Apoptosis in Multiple Myeloma Cells and Inhibits Tumor Development in a Mouse Myeloma Model

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Targeting C-Met Receptor Overcomes TRAIL-Resistance in Brain Tumors

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy